Our speakers
2016-2024

Paweł Adamkiewicz | Poland | 2018
President of the Polish Functional Rehabilitation Centre VOTUM S.A. Manager of the Healthcare Entity of the Polish Functional Rehabilitation Centre VOTUM S.A. implementing a health care programme for the treatment and rehabilitation of adult comatosed patients within the NFZ system. Vice-President of the Polish Chamber of Physiotherapists Chairman of the budgetary team of the Polish Chamber of Physiotherapists. He has been a professor at the University of Physical Education in Cracow at the Department of Rehabilitation in Neurology and Psychiatry for many years. A physiotherapist with over 20 years of professional experience in rehabilitation of patients with multi-organ traumas, in particular with craniocerebral traumas. He participated in numerous internationally recognised courses, among others on neurological rehabilitation. Member of international associations and organisations. Speaker at academic conferences and author of articles on neurological rehabilitation. top

Magdalena Ankiersztejn-Bartczak | Poland | 2023
Magdalena Ankiersztejn-Bartczak, PhD in social sciences: pedagogue, sex educator, sociologist, certified educator, HIV/AIDS consultant and counsellor, President of the Management Board of the Social Education Foundation, member of the HIV/AIDS, viral Hepatitis and Tuberculosis Civil Society Forum at the European Commission, member of the International AIDS Society, the European AIDS Clinical Society and the Polish AIDS Society (PTnAIDS), co-author of the Polish Recommendations “Principles of care for people infected with HIV”, coordinator and advisor of the Consultation and Diagnosis Points and the Mobile Harm Reduction Service, author of numerous publications and educational programmes honoured with the Red Ribbon. top

Head of the directorate Reimbursement of Medicines and Pharmaceutical Policy within the Health Care Department at the National Institute for Health and Disability Insurance (INAMI-RIZIV) in Belgium. He manages the departments responsible for administrative and scientific assessment and appraisal of reimbursement claims for medicines, orphan drugs and medical nutrition. Francis Arickx is the former secretary general for the Commission for Reimbursement of Medicines and acts as representative/expert for the Institute and Belgium on a number of national and European platforms (NM CAPR, MEDEV, MoCA). He is one of the country coordinators for the BeNeLuxA Initiative www.beneluxa.org. Francis graduated in pharmaceutical sciences from the University of Ghent, Belgium and teaches Health Policy in the Pharmaceutical Sciences Department at the University of Antwerp. top

Małgorzata Bała, MD, PhD works at the Jagiellonian University Medical College in Cracow. She has worked on various aspects of evidence-based healthcare since the beginning of her professional career. She is the co-author of several chapters in the handbook "The principles of EBM – evidence-based medicine for doctors and students of medicine students" (2008) and published many articles on systematic reviews. top

Ewa Bandurska | Poland | 2023
Doctor of health sciences with a master’s degree in public health and economics. She is an author of numerous publications on cost effectiveness analysis, integrated care and quality of life. She has many years of teaching experience and she is the author of a unique model for educating students of Public Health in the field of pharmacoeconomics. Ewa Bandurska is the head of the Public Health – management in the health system faculty (first-cycle studies). Moreover, she is a member of the Polish Pharmacoeconomics Society (currently a member of the audit committee), the Polish Society for Health Programs, the Polish Society of Social Medicine and Public Health. She also holds the position of the supervisor of the Management and Economics in Health Care scientific club at the Medical University of Gdańsk and co-supervisor of the ISPOR Student Chapter Poland – a nationwide scientific club for pharmacoeconomics students. Furthermore, Ewa Bandurska cooperates with, among others, the National Institute of Public Health – National Institute of Hygiene, the Medicover Foundation, the World Bank and other entities. top

Marion Bennie | UK | 2021
Professor of Pharmacy and Pharmacoepidemiology, University of Strathclyde and Chief Pharmacist, Public Health Scotland. Marion’s joint post is positioned to drive forward an evidence base to better inform the safe and effective use of medicines in routine clinical care. The clinical focus of her research is infection, cardiovascular and cancer including large dataset evaluation to understand evolving patterns of medicines use in routine clinical practice and the development and impact of tailored clinical decision support tools/ health interventions. Marion has lead the provisioning and curation of the Scottish Prescribing Information System (PIS) which captures all individual level community prescribing and dispensing events for the population of Scotland (5.6million) and most recently the national collection and curation of hospital individual level data to support COVID-19 efforts to understand the use and outcome of novel COVID treatments being used in clinical care outwith the clinical trial setting. Current strategic leadership roles include; Associate Director, Health Data Research (HDR) UK Scotland; Immediate past Chair, European Drug Utilisation Research Group (EuroDURG); lead for NHS Scotland Cancer Medicines Outcome Program. Marion is a: Fellow of the Royal Pharmaceutical Society, UK ; a Fellow of the Faculty of Public Health, Royal Colleges of Physicians, UK, and; a fellow of the Royal College of Physicians, Edinburgh. top

Artur Białoszewski | Poland | 2024
Preventionist, epidemiologist, economist, public and environmental health specialist. Supreme Medical Council expert in research and analysis. Director of the Strategy and Analysis Centre of the Regional Chamber of Physicians in Warsaw and of the SGH-WUM EMBA programme in health care. Masovian voivodeship consultant in the field of Environmental Health. Academic teacher at the Department of Environmental Hazard Prevention, Allergology and Immunology of the Medical University of Warsaw and the Department of Managerial Accounting at the Warsaw School of Economics. Member of the State Examination Committee of the Medical Examination Centre. Coordinator for the development of forms of postgraduate education at the Centre for Postgraduate Education of the Medical University of Warsaw. top

Physician, expert on the healthcare market, specialising in financing and strategy, as well as the pharmaceutical market.
Stefan Bogusławski has over 30 years of experience in market research and healthcare market consulting. He has managed Sequence and PEX PharmaSequence for over 10 years. Before that, between 1991 and 2007, he was a manager of the Polish and Central European branch of IMS Health and was in charge of Azyx – a research company.
Stefan Bogusławski is a graduate of the Medical University of Warsaw, he obtained the title of doctor of medicine in 1985. top

André W. Broekmans MD PhD | Netherlands | 2017
André is responsible for regulatory innovation at Lygature, an independent Dutch foundation fostering public-private partnerships in the development of medicines and medical technology. He is leading the Escher project. Currently André is coordinator of the IMI project ADAPT SMART. He has built up his regulatory experience, both with an European regulatory agency (as Head of Clinical Assessment and as Chief Executive Officer at the Dutch Medicines Evaluation Board) and with major pharmaceutical companies (senior management positions with MSD, Schering Plough, Organon). top

Michał Byliniak | Poland | 2023

Professor Stephen Campbell is Chair in Primary Care Research at The University of Manchester and until recently Director of the National Institute for Health, Greater Manchester Patient Safety Translational Research Centre. He is a health services researcher with a particular interest in the quality and patient safety of primary care and across transitional care settings including social care, with a main focus on general/family practice. He has held research appointments as Professor at the University of Melbourne, University of Canberra and the Australian National University in Australia and at the University of Heidelberg in Germany. top

Myriam de Chalendar PhD | France | 2017

John Eric Chaplin | Sweden | 2019
John Chaplin is an Associate Professor and Psychologist working for the Swedish Association of Local Authorities and Regions (SALAR), and the Sahlgrenska Academy at the University of Gothenburg, Sweden. He is the project leader for the translation and implementation of patient reported outcome measures Information System (PROMIS) into the Swedish health care system, and the Swedish health quality registries. He is supervising a research project into the development of a person-centred toolbox to aid patients in the evaluation of their health care and empower them to become co-producers of care. He has worked on Quality-Of-Life and PROM issues in national and international projects including DISABKIDS, KIDSCREEN and PROMIS. He has been Principal Investigator for European projects including the EU RESPECT project reviewing children’s needs in clinical trials research. He is currently co-chair of the International Society for Quality of Life’s Special Interest Group for Children and the PROMIS National Centre leader for Sweden. top


Oriana Ciani | Italy | 2020

Grażyna Cieślak | Poland | 2023

Justin Clark | Australia | 2023

Joan Cornet Prat | Spain | 2021
Former Director of the ECHAlliance Digital Health Observatory (Dublin), Currently Business Development Advisor at DKV Innolab Digital Health (Barcelona), Senior Expert on the elaboration of Croatian National Digital Health Plan (2020-2025), External Expert of the European Institute of Technology - Health (Munich) and Executive Director of InnoHealth Academy. top

Kathrin Cresswell | UK | 2022


Piotr Czauderna | Poland | 2016
He is head of the Department of Surgery and Urology for Children and Adolescents at the Medical University of Gdańsk. Associate professor of the Medical University of Gdańsk. In the years:
- 2006-2008 he was Representative of the Rector for the New University Hospital Programme at the Medical University of Gdańsk;
- 1996-2000 he was secretary of the General Assembly of the Polish Association of Paediatric Surgeons (PTChD),
- 2000-2003 – the secretary general of PTChD,
- 2003-2009 – head of the Gdańsk division of PTChD,
- 2009-2012 – President Elect of PTChD,
- 2012-2014 – President of PTChD;
- 2006-2012 he was head of the international Childhood Liver Tumours Strategy Group (SIOPEL);
- 2009-2015 he was Poland’s representative and member of the board of the Section of Paediatric Surgery of The European Union of Medical Specialists (UEMS)
- since 2016, president of that Section.
Piotr Czauderna is also a regional consultant on Paediatric Surgery in the Pomorskie region and Coordinator of the healthcare section at the National Development Council (NRR). He graduated from the Medical Academy In Gdańsk as well as the Gdańsk Foundation for Management Development and IAE Aix-en-Provence (MBA). top

Marcin Czech is a professor of medical and health sciences, lecturer, President of the Polish Pharmacoeconomics Society, expert in epidemiology, public health, and psychiatry. Professor at the Warsaw University of Technology and the Institute of Mother and Child, dr. hab. n. ekon. (habilitated at the Faculty of Management at the University of Warsaw). Graduate of the MBA programme at the Warsaw University of Technology, the Study of Health Economics at the University of Warsaw, the Academy of Leadership Psychology. He is the head of the Interdisciplinary Studies in Pharmaceutical Management, guest lecturer at the MBA SGH-WUM at the Medical University of Warsaw (WUM), where for almost 10 years he co-created the WUM Department of Pharmacoeconomics, Faculty of Management at the University of Warsaw and Lazarski University. Moreover, he is the head of the Department of Pharmacoeconomics and the head of the Hospital Infection Control Committee at the Institute of Mother and Child. Member of the Council of Experts of the Commissioner for Patients' Rights, member of the College of Public Health of the Polish Academy of Sciences. In the years 2017-2019, he was Deputy Minister of Health overseeing and co-managing the Department of Drug Policy and Pharmacy and responsible for Poland's international health cooperation. What is more, he is the author of over 300 papers and reports and 10 books on management, health economics, pharmacoeconomics, and quality of life, published in both foreign and Polish journals. His interests include travel, geopolitics, film, diving, sailing, and skiing. top

Aleksandra Czerw | Poland | 2020
Head of the Department of Health Economics and Medical Law of the Medical University of Warsaw. Head of the Department of Economic and System Analyses of the National Institute of Public Health – National Institute of Hygiene (NIZP-PZH). Member of Scientific Societies and editorial committees in international journals. Author of reviews of scientific publications in domestic and foreign journals. She has received awards and distinctions of the President of the Republic of Poland, the Minister of Education for her activities and has received awards from various organisations operating in the health care system. Scientific interests: health economics, healthcare management, financing in the healthcare system, measuring quality of life in chronic diseases. top

- Pricing of targeted onco-hematology medicines
- Pragmatic value assessment and HTA systems for middle-income markets
- Designing managed entry agreements and linking them to value assessment
- Negotiations and communication with payers and other governmental stakeholders
- Alternative funding strategies for middle and low-income countries

Hans-Peter Dauben | Germany | 2020

Jaroslav founded OAKS Consulting s.r.o. in 2009, after more then 15 years of experience in top management positions in Wyeth, Zentiva and Glaxo. OAKS Consulting has became in short time the leading consulting company providing full scope of services in Market Access in Czech Republic. The team currently consists of 15 specialists with professional background in medicine, pharmacology, mathematical modeling and health-economy.
top


Joanna Didkowska | Poland | 2020
She has been involved with the Department of Epidemiology of the Oncology Centre in Warsaw since the very beginning of her professional work. Currently, she is the head of the Department of Epidemiology and Cancer Prevention, as well as the head of the National Cancer Registry. Since 2016, she has been the Director of the WHO Collaborating Center for Tobacco Control and a member of the National Council for Oncology at the Minister of Health. She represents the Oncology Centre at the Marie Skłodowska-Curie Institute in Warsaw at the Governmental Population Council. Member of the Public Health Committee of the Polish Academy of Sciences. She participated in population studies concerning risk factors for cancer incidence (tobacco, alcohol, diet, demographic processes), and monitoring the geographical diversification of the incidence and mortality related to malignant neoplasms in Poland. She was the initiator and co-author of studies analysing the survival rate of Polish patients. She co-authored a yearly bulletin on malignant neoplasms in Poland, as well as a study on epidemiological forecasts. She is a member of the Polish TNM Committee of the Union for International Cancer Control (UICC, previously International Union Against Cancer), the Polish Oncological Society, Polish Oncological Union, as well as the Polish Breast Cancer Research Society. Since 2011, she has been section editor in “NOWOTWORY Journal of Oncology” and, since 2016, a member of the editorial team of “Oncology in clinical practice”. She authored over 60 publications.
top

Karen Facey worked as a statistician in pharma and medicines regulation, before becoming CEO of the first national HTA Agency in Scotland. For the past 20 years, she has worked as an international consultant in HTA, with special interests in use of real world data, evaluation of rare disease treatments and patient involvement. She is senior advisor for HTA at FIPRA, providing secretariat to the payer-led learning network, RWE4Decisions. top

Carla Fernández Barceló | Spain | 2019
Carla is a Health Technology Assessment Technician of the Innovation Unit at Hospital Clínic de Barcelona, a high-tech hospital and a reference for health care, research and medical training in Spain. In her everyday job, she works with different projects (technologies, services) assessing both the clinical and economic outcomes, to prove the value of health care technologies that are being developed inside the hospital as well as new technologies candidate to be introduced in the Hospital. Prior to this, Carla Fernandez was enrolled in d·Health Barcelona (Moebio, Biocat) a post-graduate program targeting innovation in healthcare, where she developed a 18-months project going through all the steps of the healthcare innovation cycle (detect a problem, create a solution, prototype, develop a business model and investor’s pitch to fund it). Contact with the healthcare innovation sector from a start-up perspective showed her a perspective that is useful in working in the HB-HTA department and which complemented her previous knowledge about innovation; the “seller/start-up” perspective was complemented by the “buyer/hospital” perspective. top

Wolfgang Frisch | Germany | 2016

Kamila Gaitova | Kazahstan | 2018

Krzysztof Giannopoulos | Poland | 2020

Jakub Gierczyński | Poland | 2019
Doctor of medicine and MBA graduate of London School of Economics and Stockholm Business School. Expert with 20 years of experience in health economics, public health, disease management, decision analysis, medical audits, risk management (Burton, EBM, HTA and VBHC). Co-funder of the Polish Pharmacoeconomic Society, member of the Polish Society for Public Health, HTAi, ISPOR, the Polish Coalition for Personalised Medicine and IFIC Polska. Co-author of Polish HTA guidelines for drug technologies and member of the team preparing Polish HTA guidelines for medical devices. Author of several dozen of publications, studies and reports.https://www.researchgate.net/profile/Jakub_GierczynskiMember of international projects in the field of health policy, disease management and health economics. Expert and lecturer at the Institute of Health Care Management, the Health Care MBA and the Center of VBHC at the Łazarski University, He is also the owner of Doradztwo i ekspertyzy. top

John Gillespie | Australia | 2018

Maria Giżewska | Poland | 2021


Wim Goettsch | Netherlands | 2016
Current Director of the European Network for Health Technology Assessment (EUnetHTA) JA3 Directorate. Between 2010 and 2015 he was the Project Leader of WP5 of the EUnetHTA JA1 and JA2 on Relative Effectiveness Assessments. Until the beginning of 2013, he was also the Deputy Secretary of the Medicinal Products Reimbursement Committee at Dutch National Health Care Institute. He has a PhD in immunology and an advanced education in (pharmaco)-epidemiology and pharmaco-economics. He has more than 70 publications in peer-reviewed international journals. top

Anaïs González Iglesias | Spain | 2024
Anaïs González Iglesias is a Business development consultant with extensive experience in Healthcare, particularly in Precision Medicine & Genomics. She holds a PhD in Computational Physics and is currently pursuing a PhD in Economics. Additionally, she holds a Master's degree in Health Economics and Pharma Economy, as well as a specialization in Bioinformatics, Genomics, and Molecular Biology.. Beyond her academic achievements, Anaïs actively contributes to the community as a mentor in several Acceleration Program and serves as an external evaluator for various EU-funded programs. top

Clifford Goodman | USA | 2023
Dr Clifford Goodman jest niezależnym konsultantem w dziedzinie technologii i polityk zdrowotnych. Uprzednio pełnił funkcję Wiceprezesa w The Lewin Group (spółka Optum oraz spółka zależna UnitedHealth Group), firmie konsultingowej ds. polityki zdrowotnej, z którą był związany przez 27 lat. Dr Goodman posiada czterdzieści lat doświadczenia w obszarach takich jak ocena technologii medycznych, opieka zdrowotna oparta na dowodach, wytyczne praktyk klinicznych, ekonomika zdrowia oraz nauki związane z innowacją, regulacjami i płatnościami w opiece zdrowotnej. Prowadził badania i projekty na międzynarodową skalę dla agencji rządowych; spółek zajmujących się farmaceutyką, biotechnologią i wyrobami medycznymi; instytucji dostawy opieki zdrowotnie; oraz zawodowych i branżowych grup interesu, a także grup interesu pacjentów. Ostatnio jego praca obejmuje obszary takie jak choroby przewlekłe, choroby zakaźne, nowotwory, choroby rzadkie, badania diagnostyczne, terapia genowa, farmakogenomika, medycyna spersonalizowana, leki biopodobne, kontraktowanie oparte na wartościach, społeczne uwarunkowania zdrowia i stosowanie rzeczywistych danych.
Dr Goodman pełnił funkcję przewodniczącego amerykańskiego komitetu Medicare Evidence Development and Coverage Advisory Committee (MEDCAC, 2009-12) dla agencji US Centers for Medicare and Medicaid Services (CMS). Ponadto, pełnił funkcję prezesa społeczeństwa zawodowego, Health Technology Assessment international (HTAi, 2011-13) oraz jest członkiem American Institute for Medical and Biological Engineering (AIMBE). W 2022 r. otrzymał nagrodę David Banta Distinguished Career Award w ocenie technologii medycznych od HTAi. Zdobył tytuł doktora w Wharton School of the University of Pennsylvania, tytuł magistra w dziedzinie nauk ścisłych na Instytucie Technicznym Georgii (Georgia Institute of Technology) oraz tytuł licencjata w dziedzinie nauk humanistycznych na Uniwersytecie Cornella. top

Alicia Granados Navarrete | Spain | 2016

Sylwia Grzesiak-Ambroży | Poland | 2018

Iñaki Gutiérrez-Ibarluzea | Spain (Basque Region) | 2024
Iñaki Gutierrez-Ibarluzea has a degree in Fundamental Biology and a PhD in Neuroscience from the University of the Basque Country. University Specialist in Clinical Epidemiology from the Andalusian School of Public Health and the University of Granada and Master in Bioethics from the Ramon Llul University and the Borja Institute of Bioethics and a Master on Health Innovation Management from the University of Nebrija (Madrid) and Idival. He is the Head of Knowledge Management and Evaluation of BIOEF, the Basque Foundation for Healthcare Innovation and Research, past-President of the international society HTAi (2019-2021) and the President of EuroScan/iHTS, the international network for the identification and early assessment of technologies in their life cycle since 2020. Guest Director of HTA and Market Access at Healthclusternet. Iñaki has collaborated in the implementation of HTA initiatives in different countries including Argentina, Brazil, Colombia, South Korea, Costa Rica, Ghana, Vietnam, Mexico, South Africa, Tunisia, Norway, Israel, USA, Malaysia and Italy (Early Warning System). He has also collaborated with the regional offices of the World Health Organization (WHO) in the Middle East (EMRO), Asia Pacific (WPRO) and Latin America (PAHO). WHO Consultant Expert for the Assessment of Emerging Health Technologies and Medical Devices. top

Alan Haycox | UK | 2017

Mikael Hoffmann | Sweden | 2016

Tomasz Hryniewiecki | Poland | 2023

Erica Ison | UK | 2019

Inna Ivanenko | Ukraine | 2023

Stanisław Iwańczak | Poland | 2021

Michał Jakubczyk | Poland | 2019
Professor of the Warsaw School of Economics. He works in the Department of Decision Support and Analysis of the Warsaw School of Economics (SGH). He is also the co-owner of a consulting company called HealthQuest (www.healthquest.pl). He has a background in economics (MSc, PhD and habilitation in the Warsaw School of Economics) and mathematics (bachelor at the University of Warsaw). He spent a year in the Centre for Operations Research and Econometrics in Louvain-la-Neuve, Belgium (Marie Curie scholarship) and one semester in Tippie College of Business, University of Iowa, USA (Fulbright Senior Award). His scientific interests include researching health preferences, especially in the context of imprecise description of these preferences. He has published numerous scientific articles in the field of decision support, health economy and general decision theory (among others, in the Annals of Operations Research, Central European Journal of Operations Research, Health Economics, Pharmacoeconomics, Quality of Life Research, Value in Health (cf.: http://michaljakubczyk.pl)). He is a member of scientific associations such as The EuroQol Group and the International Academy of Health Preference Research (IAHPR). He led the winning team in the global health preference and choice modelling competition organised by IAHPR (http://iahpr.org/eq-dce-competition/). He gives lectures on decision analysis at bachelor, master’s and MBA levels, as well as training cuorses for various institutions (e.g. the National Health Fund, the Ministry of Health, the Agency for Health Technology Assessment and Tariffs, private companies). He co-directs the MBA programme offered jointly by the Warsaw School of Economics and the Medical University of Warsaw. top

Krzysztof Jakubiak | Poland | 2022

Jerzy Jaroszewicz | Poland | 2024 |
Professor Jerzy Jaroszewicz, specialist in infectious diseases and hepatologist, is Head of the Clinical Department of Infectious Diseases and Hepatology of the Medical University of Silesia in Katowice. Moreover, he acts as President of the Polish Association for the Study of the Liver, is a member of the Polish Groups of Experts for HBV, HCV, COVID-19 and for Non-Alcoholic Fatty Liver Disease (NAFLD) and is a member of the HBV expert panel of the European Association for the Study of Liver (EASL). He specialises in diagnosis and treatment of HAV, HBV, HCV, HEV, autoimmune, steatotic, genetic and other liver diseases (research on infectious diseases). He is also involved in the treatment of tick-borne diseases (including Lyme borreliosis), other viral, bacterial, and fungal infectious diseases and immunoprophylaxis. He graduated from the Medical University of Bialystok in 1999. He acquired his scientific skills during numerous internships abroad (Aachen, Germany and Florence, Italy) in the field of pathophysiology and liver cell culture techniques, among others. In the years 2008-2010, he carried out research under grants (DAAD, Erasmus, Deutsche Leberstiftung) at the Clinic of Gastroenterology, Hepatology and Endocrinology of the Hannover Medical School. He is the author and co-author of more than 150 publications in journals on the Philadelphia List, numerous chapters in textbooks and conference reports on primarily clinical and molecular aspects of viral hepatitis. top

Urszula Jaworska | Poland | 2018

Director of the Health Department of the Pomeranian Voivodeship Marshal's Office. Graduate of the Medical Faculty of the Medical Academy in Gdańsk (nowadays known as the Medical University of Gdańsk). Specialist in Public Health. He has a PhD in medical sciences and holds the position of assistant professor in the Department of Public Health and Social Medicine. Author of several dozen articles on public health concerning, in particular, the field of management and organisation of health care, economic aspects and epidemiology. Councilor of the City of Gdańsk (1994-1998) and chairman of the City Commission for Solving Alcohol Problems (1997-2001). Deputy Healthcare Director at the University Clinical Centre in Gdańsk (2010-2014), Deputy Director and then Director of the Pomeranian Branch of the National Health Fund (2008-2009 and then 2013/14); President of the National Health Fund between June 2014 and March 2016. top

Bradley Johnston | Canada | 2018

Mateusz Juchniewicz | Poland | 2021


Katarzyna Anna Kacperczyk | Poland | 2024 |
Long-time government official. She has experience in international cooperation and support for economic and investment cooperation. Graduate of the University of Warsaw, Institute of International Relations and the prestigious Columbia University in New York (economics and management). She also studied at the European Institute (Legal Affairs Section) at the Saarland University in Germany and as part of the European Studies Programme – at the Warsaw School of Economics. For many years, Katarzyna Kacperczyk held prominent official and diplomatic positions at the Ministry of Foreign Affairs, including as the director of the Department of Economic Cooperation and Undersecretary of State (2013-2016) responsible for supporting the interests of the Polish economy and Polish businesses. In the years 2005-2008, she was a diplomat at the Permanent Representation of the Republic of Poland to the United Nations in New York, where she was responsible, among others, for issues regarding reforming of the Organisation. She served as advisor in the Chancellery of the Prime Minister. In 2018 she started working at the Warsaw School of Economics, where she was responsible for the development of international cooperation and supervised and led projects funded by national and EU funds. She was a lecturer at the Warsaw School of Economics, the National School of Public Administration and at the Lazarski University. In the years 2013-2015, she was a member of numerous government committees, including the Council of Ministers Committee for Digital Affairs, the Committee on Export Insurance Policy and the Investment Committee of strategic importance to the economy. She is a Centre for International Relations expert. Katarzyna Kacperczyk holds numerous awards and distinctions, including: Gold Cross of Merit (2012), Order of the Crown (Belgium) and class IV Order of Tomáš Garrigue Masaryk of the President of the Czech Republic. top

Rabia Kahveci | Ukraine | 2022
Rabia Kahveci is the Vice President of the HTAi, and Senior Technical Advisor for Pharmaceutical Policy and Governance in the SAFEMed project, in Kyiv Ukraine. SAFEMed project is a USAID funded and MSH led project that supports Ukrainian government. SAFEMed applies health system strengthening best practices to create evidence-based interventions and strengthen Ukraine’s pharmaceutical system. Her area of responsibility is to support priority setting and HTA, including and beyond capacity building and HTA institutionalization in Ukraine, as well as supporting pricing and reimbursement policies for health technologies. Besides her full time work at SAFEMed, she has been an active member of the HTAi for many years and served in the Board of Directors twice before being elected as the VP. During these years she chaired Annual Meeting Committee; co-chaired International Scientific Program Committee of HTAi Annual Meeting in Rome (2017); chaired Developing Countries Interest Group, co-chaired Medical Devices Interest Group; chaired the Organizing Committee of HTAi Regional Meeting hosted by Ukraine, in September 2020. She also chairs the Eurasian HTA Initiative that has members from 9 countries from Balkans and Central Asia. She acted as the President of the Turkish Evidence-Based Medicine Society for eight years. Prior to her position with SAFEMed, she was the director of a hospital-based HTA center in Turkey (ANHTA) that covered HTA, innovation for medical devices, and real-world evidence. She was a professor of family medicine in the same hospital. She contributed to several national and international projects around HTA, including EUnetHTA and AdHopHTA. ANHTA showed an impact of 2.5 million euros savings in 3 years, and stood as an outstanding example for HB-HTA at the global level. She served as the national clinical quality coordinator of the Turkish Ministry of Health in 2017, where she coordinated all activities involving HTA, clinical guidelines and quality. Prior to ANHTA, she served as a member of the Pharmaceuticals Reimbursement Committee of the Turkish Social Security Institution during the transition to universal health coverage and was a co-author of the reimbursement guidelines. She worked in the Turkish Medicines Agency on pricing and reimbursement of pharmaceuticals and led the HTA work of the Agency. Being an academic and medical doctor by background, with a degree in HTA, Prof. Kahveci authored over 150 peer-reviewed articles, 8 books and delivered over 300 presentations in international meetings on HTA. top

Ewa Kawiak-Jawor | Poland | 2022

Alastair Kent | UK | 2016

Paulina Kieszkowska-Knapik | Poland | 2017
Advises companies and industry organisations on healthcare law, especially the Pharmaceutical Law, the Reimbursement Act and the Act on Medical Activity. Paulina is also a co-founder of the Lege Pharmaciae Foundation, a non-governmental organisation formed to analyse and hold a public debate on defects in legal regulations in the healthcare sector. Paulina Kieszkowska-Knapik works with the Civic Legislation Forum at the Stefan Batory Foundation on the introduction of European lawmaking standards in Poland. Recommended for many years by Polish (Rzeczpospolita and Dziennik Gazeta Prawna) and international (Chambers Europe, PLC Which Lawyer) rankings as the best specialist in pharmaceutical law in Poland. She advises patient organisations pro bono, including the Polish Coalition of Cancer Patient Organisations, the Alivia Foundation and the Federation of Polish Patients. Paulina worked at Baker & McKenzie law firm for a decade, having previously worked at CMS Cameron McKenna. top

Miroslav Klugar | Czech Republic | 2017

Katarzyna Kolasa | Poland | 2016

Polish local government official, physician and activist of the German minority in Poland since 2010 to 2020, Deputy Marshal of the Opolskie Voivodeship. In the years 1999-2002, he was the director of the Department of Health and Social Policy of the Marshal’s Office of the Opolskie Voivodeship. In 2002, he was transferred to the position of Deputy Director for Medical Matters of the Regional Health Fund in Opole, and then took up a similar position in the Opole branch of the National Health Fund. He was also active in his community, participating in consultations regarding changes in the state health policy and the antibiotic therapy rationalisation programme. He was politically involved in the activity of the German minority in Poland within the Social and Cultural Association of Germans of Opole Silesia. In 2017, together with other German Minority members, he co-founded the “Regionalna. Mniejszość z Większością” (Regional. Minority with the Majority) party; in 2018 he became its deputy chairman. He taught classes at physician courses, as well as classes at the Pharmacoeconomics, Marketing and Pharmaceutical Law College at the Warsaw University of Technology. Roman Jacek Kolek has published scientific papers in the field of public health and health care finance, cost analyses of expenditure on health services provided to the insured, as well as lectures for physicians as part of training sessions and courses in public health and health insurance. He co-organised numerous conferences in the field of health policy and financing of health services, including the British-Polish Healthcare Forum, Polish-Ukrainian Healthcare Forum and the Polish-German Health Forum. He authored and co-authored numerous publications in the field of public health and financing of health services. In 2020, during the pandemic, he resigned from the position of Deputy Marshal of the Opolskie Voivodeship, returned to the profession of an anesthesiologist, currently he is the Deputy Director of the Provincial Hospital for healthcare, he is the Quality Representative. top

Medical Devices Market Access & HTA Lead Europe East and Israel at Organon. Experienced Market Access Executive with a passion for driving innovation and delivering results. Over 1000 projects completed, including designing and bringing new innovative products to market. He believes it is vital to add value, improve and find efficiencies in all you do. top

Konrad Korbiński | Poland | 2024

Mariusz Kordecki | Poland | 2020

Expert in health technology assessment and health economics. For ten years she has been specialising in quality assessment (audits) of analyses included in HTA reports. Author and co-author of systemic studies in healthcare and scoping aiming at determining the directions and scope of analyses required for reimbursement and pricing purposes. Partner in HTA Audit and HTA Registry. Active instructor in the fields of EBM, HTA and Pricing in public institutions and the pharmaceutical industry. top

Dorota Korycińska | Poland | 2020
Dorota Korycińska is a social psychologist. She has been actively helping patients and families struggling with rare diseases, as well as patients with disabilities for 20 years. She is the co-founder and, since 2009, the President of the Management Board of the Neurofibromatosis Association Poland (formerly the Association of Patients with Von Recklinghausen’s Disease and Other Phakomatoses). For years, she has ceaselessly worked to provide systemic healthcare to patients with neurofibromatosis. She is the President of the Management Board of the Polish National Oncological Federation. top

Anna Kostera-Pruszczyk | Poland | 2021


Oskar Kowalski | Poland | 2020


Undersecretary of State at the Ministry of Health in 2017–2019. Former Deputy director of the Agency for Medical Technology Assessment and an adjunct professor at the Institute of Public Health of the Jagiellonian University. From 2009 to 2011 he was on the board of Pfizer Polska sp. Z oo. Then he was the director of the Drawski Specialist Center (2012-2013) and the Specialist Hospital. S. Żeromski SPZOZ in Cracow (2013-2016). Undersecretary of State at the Ministry of Health. He is an honorary member of the College of Family Physicians in Poland. In his account he has, among others. Delegation of the Baltic Sea Task Force (later Northern Diamension) Experts Group for Primary Health Care and EQUIP - European quality workshop group. He was also an expert on the World Health Organization and the World Health Organization, as well as the project manager for the Data for Decision Makers project (Harvard-Jagiellonian Consortium for Health). top

Dušan Krstić | Czech Republic | 2018
Regional Sales Manager at EBSCO Information Services, a graduate of the University of Kragujevac (Serbia) with post graduate studies in Microbiology and Molecular Oncology at Masaryk University (Czech Republic). Since 2008, he was working is the medical field, specializing in technologies for Dermatology, Rehabilitation and Oncology. From 2017, he is managing Medical and Corporate market in Central and North-east Europe and CIS Countries, in EBSCO Information Services – world’s leading aggregator of medical and scientific literature. His primary aim is to provide access to evidence based medical information and primary medical, scientific and business literature to healthcare development organizations, healthcare professionals and companies operating in any field of healthcare for improvement of healthcare services, medical technologies and medical products development, assessment and vigilance. top

Anna Kupiecka | Poland | 2018

Professor Brygida Kwiatkowska is a rheumatologist; she was acting Clinical Affairs Director of the National Geriatrics, Rheumatology and Rehabilitation Institute (NIGRiR) in Warsaw since February 2013 and Deputy Clinical Affairs Director since 2018. In 2009, Prof. Kwiatkowska became acting Head of the Department of Early Arthritis Diagnosis of the Rheumatology Institute. She has been the Head of the Clinic of Early Arthritis as an Associate Professor in 2012. Moreover, she has been a member of the Scientific Council of the Rheumatology Institute for 14 years. In the years 2015-2017, she was the President of the NIGRiR Scientific Council. President of the National Rheumatology Council, she worked as the President of the Warsaw Division of the Polish Society for Rheumatology for 7 years; currently she is the Deputy President. Professor Brygida Kwiatkowska has been the National Consultant in the field of rheumatology since May 2021. She is also the President of the Polish Society of Autoimmune Diseases. Her research interests include diagnostics and treatment of rheumatic diseases. She conducts her work multidirectionally, by expanding the knowledge from other fields of medicine related to rheumatic diseases. Prof. Kwiatkowska promotes the use of new diagnostic techniques for diagnosing rheumatic diseases; she introduces state-of-the-art therapeutic methods. Her scientific contribution includes 52 publications. She is the lead author of most of them, meaning she is the key person responsible for the subject concept, processing of the results and preparation for print. top

Miranda W. Langendam | Netherlands | 2022

Ewa Lech-Marańda | Poland | 2023
Professor Ewa Lech-Marańda specialises in internal diseases, haematology, clinical transplantology and clinical immunology. She is the author of over 130 original works, review works and textbook chapters. In the years 1995-2010 she was an assistant and adjunct at the Department of Haematology of the Medical University of Łódź. In 2010, she started working at the Institute of Haematology and Transfusion Medicine in Warsaw as the deputy head of the Haematology Clinic. In the years 2015-2017, she served as the deputy Director for Therapeutics at the Institute, and in 2017 she was appointed by the Minister of Health as the Director of the Institute of Haematology and Transfusion Medicine. Since 2013, she has also been the head of the Haematology and Transfusion Medicine Clinic at the Centre of Postgraduate Medical Education in Warsaw and the voivodeship consultant in the field of haematology for the Masovian Voivodeship; what is more, since 2018, she has been working as the national consultant in the field of haematology. top

Line Helen Linstad | Norway | 2020

Head of Medical Training and Simulation Centre, University of Warmia and Mazury in Olsztyn, vice-President of The Polish Society for Medical Communication, healthcare expert of the Jagiellonian Club Analytical Centre, President of Polish Prader–Willi Syndrome Association. Member of the Expert Board to the Patients Ombudsman. top



Maciej Małecki | Poland | 2018
He graduated from the Faculty of Medicine of the Nicolaus Copernicus Medical Academy in Cracow in 1988. Specialist in internal medicine, diabetology, laboratory diagnostics and endocrinology. In 1998, he defended his PhD thesis entitled "Searching for genes predisposing to type 2 diabetes in chromosome 20q" with honours at the Jagiellonian University Medical College. The thesis was awarded the Aurelia Baczko Award from the Polish Foundation for the Promotion of Science of the Society for Supporting Sciences for the best doctoral dissertation in the field of non-surgical clinical medicine. In 2004, he received a postdoctoral degree after submitting his dissertation entitled "Molecular basis of type 2 diabetes – selected pathogenetic and clinical issues". In 2009, he received the Professor title. Between 1993 and 2000, he worked as an assistant at the Department of Metabolic Diseases of the Jagiellonian University Medical College; in 2000, he became an adjunct there; in 2008 he became the dean of the department – as an associate professor since 2009 and, since 2013, as a professor of the Jagiellonian University. Between the years 1996 and 1999 he was a scholar at the Joslin Diabetes Center in Boston, affiliated with the Harvard Medical School. His scientific interests include the genetic background of monogenic and type 2 diabetes, as well as clinical research in diabetes, especially related to pregnancy. He is the author and co-author of around 180 scientific articles, including 150 original works; his works have been quoted over 3000 times until the year 2017 (IF of about 600, 26 in the Hirsch index). He has been a member of the General Board of the Polish Diabetes Association (since 2007) and the President of the Association since 2015. He was a board member of the European Society of Clinical Investigation. He is a member of the European Association for the Study of Diabetes, and an EASD expert on etiological diabetes. He participates in the works of the EASD Study Group on the Genetics of Diabetes. In 2001, he received an award from the Polish Diabetes Association for his achievements in the field of diabetology, and in 2005, he was invited to give a lecture under the auspices of Jakub Węgierko during the Polish Diabetes Association Conference. For his outstanding scientifical achievements, he was recognised with an award of the Prime Minister (2006) and also received a team award from the Minister of Health (2009). In 2013, he received a Browicz Award from the Polish Academy of Learning, and in 2014 he received a Jagiellonian Laurel and a Śniadecki Award from the Polish Academy of Sciences. He has been a member of the Polish Academy of Learning since 2017. He is a reviewer in Endocrine Review, Diabetes, Diabetes Care, Diabetologia, Diabetic Medicine and several Polish journals and also an editor in the European Journal of Clinical Investigation and Diabetologia Praktyczna. He is an EU expert in the evaluation of scientific projects within the FP6, FP7 and Ideas programmes. He has published articles in world-leading scientific journals, including Nature Genetics, Nature Clinical Practice Neurology, New England Journal of Medicine, Diabetes, Diabetologia, Diabetes Care, Stroke, Neurology and others. Between the years 2008 and 2012, he was a deputy dean for organisation and curriculum at the Faculty of Medicine of the Jagiellonian University Medical College; between 2012 and 2016 he was the Jagiellonian University dean's proxy for research and development at the Jagiellonian University Medical College. Since 2016, he has been the Dean of the Faculty of Medicine of the Jagiellonian University Medical College. top

Monika Małowicka | Poland | 2022

Ileana Mardare | Romania | 2016

Edyta Masłowska-Parafian | Poland | 2024

Piotr Merks | Poland | 2018

Piotr Miazga | Poland | 2018
Piotr graduated from the Jan Kochanowski University in Kielce and the Cracow University of Economics. He is a Market Access Consultant and the Director for Analytical Development in HTA Consulting. He specialises in financing health services, as well as in the field of local self-government health programmes. He is responsible for the development of institutional cooperation in Poland and CEE countries. top


Magdalena Ruth Moshi | Australia | 2023

Marta Musidłowska | Poland | 2023

Maciej Niewada | Poland | 2020

Rafał Niżankowski | Poland | 2016

Tanja Novakovic MSc Pharm is director of ZEM Solutions Ltd and the president of the Pharmacoeconomics Section within the Pharmaceutical Association of Serbia. After finished postgraduate studies in Health Economics at Ghent University in Belgium she has made significant contributions to developing knowledge and experience in heath economics and HTA, organizing many international Conferences and bringing together world experts in this field. She is author of the “Handbook for pharmacoeconomic evaluations” (2006), the first publication in the field of pharmacoeconomics in the Serbian language, Serbian pharmacoeconomic guidelines (2011) and co-author of the book Health Economics (2014). Tanja participated in several projects in a wide range of fields, including: Big Data, disease areas such as oncology, rare diseases, nutrition, Rheumatology, biosimilars and has previously been involved in World Bank and Ministry of Health of Serbia projects. Tanja has organized and presented in many national meetings and international conferences which have resulted in international cooperation in education and the developing of pharmacoeconomics and HTA in Serbia. top

James O’Brien | Australia | 2020
A Chair, Director, Advisory Council Member and CEO in International Prader-Willi Syndrome Organisation (IPWSO) with over twenty years of board level experience across the public, commercial & not for profit sectors with particular experience in the construction, education and disability services industries. The president of the Prader-Willi Syndrome (Australia) where he has recently steered the amalgamation of State PWS Associations to a unified PWS Australia. Vice Chair of the International Prader-Willi Syndrome Organisation, enabling both Australian and global initiatives and research that have improved the lives of those living with PWS world wide; and Council Member of Global Genes RARE Global Advocacy Leadership Council, championing the needs and explored ways to establish and foster person and family support organisations in every syndrome in every country. Founding Director and CEO of PWS Better Living Foundation Ltd where he is exploring local housing development opportunities for individuals and families living with PWS. He is a Graduate of the Australian Institute of Company Directors' Company Directors Course, he hold a Commercial Real Estate License and a Graduate Diploma of Applied Finance. top

Daniel Ollendorf | USA | 2023

Wija Oortwijn is affiliated with Radboud University Medical Centre Nijmegen, Department for Health Evidence (the Netherlands). She studied health sciences and holds a PhD in Medicine (Priority setting for Health Technology Assessment - HTA). She has more than 25 years of relevant professional experience in HTA and health policy analysis. She led studies on mapping the level of HTA in countries around the globe and was involved in the research project INTEGRATE-HTA (www.integrate-hta.eu), aimed to develop concepts and methods to enable patient-centred, integrated assessments of the effectiveness, and the economic, social, cultural, and ethical issues of complex technologies that take context and implementation issues into account. Recently, she concluded a project on improving HTA and decision-making in 10 selected countries around the globe (published in Value in Health), and a project to describe the extent to which HTA is aligned with values and principles that underpin the health system in a selection of countries. Currently, she is developing a practical guide for HTA organizations regarding the implementation of ‘evidence-informed deliberative processes’ (EDPs). EDPs provide guidance to HTA organizations to improve their processes towards more legitimate decision-making. EDPs is based on rational decision-making through evidence-informed evaluation of identified values (as reflected in multi-criteria decision analyses - MCDA) as well as fair decision-making (as reflected in the accountability for reasonableness approach – A4R). She is a founding Member of the Dutch (NVTAG) and the International Society for HTA (HTAi), past Board Member of both societies and has been co-chair of the HTAi/INAHTA Interest Group on Ethics from 2011 until 2017. Currently, she is a member of the HTAi Scientific Development and Capacity Building Advisory Committee, co-chairing the International Working Group to update the definition of HTA, and is associate editor of the International Journal of Technology Assessment in Health Care. Furthermore, she is the scientific secretary of HTAi’s Global Policy Forum: for 2016-2017 (on value frameworks), for 2017-2018 (on horizon scanning) and for 2018-2019 (on real world evidence). top

Sylvia Atisa Opanga | Kenya | 2022


Bonny Parkinson | Australia | 2023

Chris L. Pashos | USA | 2021

Marcin Pasiarski | Poland | 2023

Marta Pawłowska | Poland | 2024
Expert in health promotion and disease prevention, in particular overweight prevention and systemic solutions to reduce obesity in children and families. She has a knowledge in this area and is gaining unique experience on the international market. Marta Pawłowska is also a strategy and health education projects specialist, consultant to businesses, NGOs, and local government administration. Moreover, she is the Co-founder and President of the Presidium of the Partnership for the Prevention and Treatment of Obesity, initiator and co-author of the strategic assumptions of the national plan for reducing obesity in Poland. She has 25 years of experience in managing health, social, and educational campaigns, implemented in Poland and abroad, as well as in crisis communication. In years 2019-2021, she acted as the Director of the Health Prevention Bureau (Biuro Profilaktyki Zdrowotnej) of the Central Office of National Health Fund. Graduate of the MBA Oxford Brooks University and MBA in Health Care at the Lazarski University. Author of health publications, family health specialist with 10 years of expertise in eating disorders and compulsive behaviours, narrative therapist in the certification process at the Dulwich Centre in Australia. top

Serhii Pekh | Ukraine | 2023
Serhii Pekh is a unique influencer whose activities on social media have meaningful impact on society. His main goal is to make the rules of legal residence in Poland and procedures for entering Poland more commonly known, not only for Ukrainian citizens, but also for other nationalities. As a community activist, Serhii is a co-founder of Wellcome EU foundation, which aims to help refugees from various countries in difficult times. Serhii Pekh is not only an influencer, but also a philanthropist. His involvement in helping refugees of various nationalities shows that he always puts humanitarian matters first. Moreover, as an investor, he’s aware of the role that business can play in creating positive social changes. His versatility and psychological knowledge help him understand how social media works and what is the best way of conveying his social messages. Serhii Pekh is an individual who inspires and motivates others to work for the common good and understands the needs of refugees and migrants in Poland, regardless of their country of origin. top

Barbara Pepke | Poland | 2023
President of Gwiazda Nadziei Foundation. Leader of the Hepatology Coalition. She is a campaigner for patients suffering from liver diseases. Barbara is a former hepatitis C patient herself. What is more, she has co-founded the Gwiazda Nadziei Foundation and has been its President for over 15 years. When it comes to her professional life, Barbara has been associated with the local government for over 25 years, and currently with the voivodship government. She is a Councilwoman of the Mikołajów County for the 5th Term, and currently the Chairwoman of the Mikołajów County for the 6th Term. She has initiated numerous social campaigns, trainings and educational programmes in the field of liver disease and cancer prevention. Moreover, she co-created numerous educational campaigns directed at young people, teachers, residents, physicians and, lately, also Ukrainian refugees. Barbara is the originator, co-author and coordinator of the publications published by the Gwiazda Nadziei Foundation, used in campaigns promoting free tests and educating GPs and teachers on the current knowledge about hepatotropic virus infections. She strongly believes that health and human life are of paramount value. top

Janina Petelczyc | Poland | 2024
Social security expert specialising in particular in pension systems, ESG funds, and international comparative social policy. Since 2020, she has been a member of the Occupational Pensions Stakeholder Group of the European Insurance and Occupational Pensions Authority. Her scientific interests primarily include social security. top


Ozren Pezo | Croatia | 2021


Vinciane Pirard | Belgium | 2017

Robert Plisko is CEO at HTA Consulting since 2006 and one of the company’s founders. He obtained his Master of Economics title at the Cracow University of Economics. His professional career started at the National Centre for Quality Assessment in Healthcare. Robert Plisko is the author of numerous publications on HTA and health care. He is head of the Economic Analyses Department at HTA Consulting. top

Marta Podhorecka | Poland | 2024
Prof. Marta Podhorecka is a physiotherapist, specialist in health promotion and health education, creator and implementer of projects dedicated to senior citizens, professor at the Department of Geriatrics of Collegium Medicum Nicolaus Copernicus University, President of the Senior Citizen Policy Council at the Ministry for Senior Policy. She is a member of the Bydgoszcz Equal Treatment Council, International Association of Gerontology, vice-president of the Kujawsko-Pomorskie branch of the Polish Society of Gerontology and a member of the Polish Physiotherapy Association Management Board. In recognition of her popularisation activities and research for the benefit of senior citizens, and in particular her initiatives to counteract discrimination against senior citizens and promote intergenerational integration, she was awarded the first title of Senior Citizen Supporter” (“Przyjaciel Seniora”) in 2019 by the Jolanta Kwasniewska Foundation “Communication without Barriers”. top

Tadeusz Popiela | Poland | 2018

Maarten J. Postma | Netherlands | 2021

Csilla Pozsgay | Hungary | 2017

Managing Director of CEESTAHC. Graduate of the Faculty of Medicine of the Medical University in Łódź and Postgraduate Health Care Management Studies in the Nofer Institute of Occupational Medicine. Expert in cooperation and creation of health projects with local government units, with many years of experience in creating an educational platform for developing high-quality health programmes in important areas of public health. President of the European Foundation for Solving Health Problems (Europejska Fundacja Rozwiązywania Problemów Zdrowotnych). Co-creator of the “Zdrowie/Człowiek/Profilaktyka” educational programme, aimed at local governments and employers. Initiator of www.dobreprogramyzdrowotne.pl, a website containing a Health Programme Creator and educational materials for creators of health policy programmes. top

Maria Psenkova | Slovakia | 2016

Graduated from the Faculty of Computer Science at the University of Silesia, profession IT specialist. As a patient, actively involved in patient organizations for over 20 years. Board Member of European Patients Forum (EPF). I am also pleased to represent EPF in Patients’ and Consumers’ Working Party (PCWP) within the European Medicines Agency (EMA). Through the EMA, I am involved in various projects as digital and media working group, electronic product information, vaccination and more. I am also a board member of the Polish Neuromuscular Diseases Association (PTCHNM) and European Alliance of Muscular Dystrophy Associations (EAMDA Slovenia). Co-organiser of many international and national conferences for patients with neuro - muscular diseases. Co-author of publication:“Be an ambassador for change that you would like to see”: a call to action to all stakeholders for co-creation in healthcare and medical research to improve quality of life of people with a neuromuscular disease (Orphanet Journal of Rare Diseases). In private life - enthusiast of modern technologies and modern devices facilitating mobility. top

Elizabeth A. Rider | USA | 2022
Elizabeth A. Rider, MSW, MD is a pediatrician and medical educator; leader of the Transforming Healthcare Relationships: Values, Learning Environments, and Organizational Culture project; and founder and Director, Boston Children’s Hospital / Harvard Medical School Faculty Fellowships in Humanism/ Professionalism, and Interprofessional Leadership. On the faculty of Harvard Medical School and the Harvard Macy Institute, she directs the international course Difficult Conversations in Healthcare. She served as Director of Academic Programs for the former Institute for Professionalism and Ethical Practice (2007-2020). Dr. Rider is a senior fellow and former Chair of the Medicine Academy of the National Academies of Practice. She is a founder of the International Consortium for Communication in Healthcare (IC4CH) and leads the International Charter for Human Values in Healthcare initiative, an interprofessional collaborative effort to restore attention to core values and skilled communication in healthcare. She also serves as an Associate Editor for Patient Education and Counseling. Dr. Rider has been recognized internationally for her work and has been an invited speaker / consultant in 10 countries. Her current research includes relational learning, values, communication skills, professionalism, medical /interprofessional education, as well as national collaborative studies to identify promoters /barriers to humanistic practice and education, and humanistic leadership and organizational culture change to mitigate burnout and enhance wellbeing. top


Tomasz Rowiński | Poland | 2024
Doctor of Psychology, assistant professor at the SGH Warsaw School of Economics – ThinkTank SGH for health care, member of the Council for Mental Health at the Minister of Health, member of the Social Welfare Reform Team at the Minister of Family, Labour and Social Policy, member of the Child Death Review Team at the Minister of Justice. He is the author or co-author of more than forty publications and presented sessions or lectures at more than 100 scientific and professional conferences in the field of mental health. He created the first community mental health centre for children and youth. He based the centre on a scientifically validated model of mental health, which was the basis for organising public services for families, children and youth. He was awarded the “Golden Synapse” distinction by the psychiatric community for his idea and its implementation. What is more, he was involved in the implementation of the model of deinstitutionalisation of public mental health services for children and youth in many parts of Poland. He is the initiator of databases for public policy, which are essential for decision-making in public services at government and local government levels. Tomasz Rowiński is committed to establishing the legal basis and mechanisms for multisectoral cooperation in the area of mental health from the public value perspective. top

Andrzej Ryś | Poland | 2022


Joanna Rzempała | Poland | 2021

Katarzyna Sabiłło | Poland | 2017

Stefan Sauerland | Germany | 2019
Stefan Sauerland joined IQWiG (Institute for Quality and Efficiency in Healthcare) in January 2010. As Head of the Department for Non-Pharmacological Treatments, he is responsible for the scientific evaluation of non-pharmacological therapies (including medical devices), diagnostic tests and control procedures. IQWiG is responsible for the preparation of evidence-based reports that support reimbursement decisions at national level within the German healthcare system. Prof. Sauerland has more than 12 years of experience in surgical research, first at the University of Cologne and then at the University of Witten/Herdecke. His main areas of interest have been clinical trials, clinical guidelines and meta-analyses. He has published more than 250 articles, more than 150 of which are in the Medline database. In 2005, he received the DKV Cochrane Award for his review of laparoscopic appendectomy for Cochrane. He obtained his MD from the University of Cologne and his M.P.H. from the University of Dusseldorf. In 2019, he became an assistant professor at the University of Cologne. top

Natalie Schellack | South Africa | 2022

Michael Schlander | Germany | 2023
Michael Schlander is Professor of Health Economics (at AWI – Alfred Weber Institute for Economics and at the Mannheim Medical Faculty) of the University of Heidelberg, currently on leave of absence to act as foundation Head of the Division of Health Economics for the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ), Heidelberg, Germany (since 2017). He has been founding chairman of the not-for-profit “Institute for Innovation & Valuation in Health Care” (InnoValHC e.V.) in Wiesbaden, Germany (since 2005), and has acted a scientific advisor of its consulting and management branch, Inno-Val-HC-Forschungsgesellschaft mbH (InnoValHC Research Inc., also since 2005). He is a member of numerous scientific associations, including the Drug Information Association (DIA), the International Health Economics Association (iHEA), and the International Society for Pharmacoeconomics and Outcomes Research (ISPOR); in 2008, he was a co-founder of the German Society for Health Economics (Deutsche Gesellschaft für Gesundheitsökonomie, DGGÖ). He further acted as the scientific program chair for the 15th Annual European Congress of ISPOR in 2012, with more than 3,500 attendants. After six years in experimental brain research and clinical neurology (at the Universities of Frankfurt a.M. and Mainz), he joined the international biopharmaceutical industry in 1987, where he spent 15 years in executive roles in clinical development (1987-1993), marketing (1993-1999), and general management (1999-2002) in Belgium, Germany, Switzerland, and the United States. His scientific publications include two monographs, on ‘The Contribution of Health Economics to Market-Oriented Pharmaceutical Research and Development’ (Witten/Herdecke University Press; Witten, Germany: 1998) and on ‘Health Technology Assessments by the National Institute for Health and Clinical Excellence (NICE)’ in England and Wales (Springer; New York, NY: 2007). top

Ad R. Schuurman MBA | Netherlands | 2017

Holger Schünemann | Canada | 2020

Michał Seweryn | Poland | 2023
President of EconMed Europe, graduate of CMUJ, specialist in public health and epidemiology, Doctor of Economics in the field of health economics. He specialises in health economics, HTA and drug management. An expert at the European Commission (evaluating grants in the HORIZON programme), long-time lecturer of HTA and health economics – assistant professor at Collegium Medicum of the Jagiellonian University (2009-2016). In the past, he served as the Lesser Poland Provincial Sanitary Inspector and the Head of the Department of Drug Administration of the Lesser Poland Provincial Branch of the National Health Fund. Michał Seweryn is the author of scientific publications and specialised studies in the field of health economics and epidemiology. top

Nabil Seyidov | Azerbaijan | 2022

Markus Siebert | Belgium | 2018

Steven Simoens | Belgium | 2017

Sociologist – HTA expert – with more than 20 years of professional experience in public and private institutions related to health technology assessment (HTA/EBM), total quality management (TQM), clinical indicators, quality of life assessment, health insurance, and clinical research. He has held management positions in the CEESTAHC Association, WHC and Medicea Foundations, clinical research centres and numerous companies involved in broadly defined quality, ancillary insurance, and HTA. He currently holds the position of Director at the AOTMiT’s Branch Office in Cracow. He was the initiator and organiser of the International EBHC Symposium (2004-11) of the CEESTAHC Association, and of the conference series entitled “Innovations in Medicine” of the WHC Foundation. Jacek Siwiec is a manager, organiser, coach in trainings and several hundred training programmes in the field of EBM/EBHC/HTA/GCP, and an academic lecturer – at i.a. postgraduate studies in HTA at Institute of Public Health at Jagiellonian University Medical College (PRO-QUO HEALTH, HB-HTA). He has held advisory roles as, i.a., a member of the Ministry of Health’s Team for the Translation of Maps of Healthcare Needs, expert of the AOTMiT’s Tariffs Council, HTA coordinator of the Pointer project. Additionally, he is a member of teams and co-author of the Minister of Health’s “IOWISZ” tool. Jacek Siwiec is the co-author of HTA studies and expert consultations for Ministries of Health of the following Serbia (on behalf of the World Bank) and Ukraine. He has cooperated with various international institutions such as WHO (HEN), EUnetHTA, HTAi, World Bank and DG SANCO – member of the Expert Group on Health Systems Performance Assessment (HSPA), as well as Polish and foreign universities. Currently, he participates in several task forces and consulting teams, such as Voivodship Health Needs Mapping Teams, or in the work of the President of the Republic of Poland’s Working Group on 75 + Centres, as well as in the work of the Steering Committee for the Coordination of EFSI Interventions in the Health Sector. He has been an expert member, Polish representative for HTA methodology to the EU team – Coordination Group on Health Technology Assessment (CG-HTA), dealing with the commonality of HTA activities in the EU, since 2023. top

Iwona Skrzekowska-Baran | Poland | 2018


Agnieszka Słowik | Poland | 2018

Sophie Söderholm Werkö | Sweden | 2021

Sophie Staniszewska | UK | 2021


Wojciech Szefke | Poland | 2017


Bartosz Świdrak | Poland | 2017

Doctor of Health Sciences, public health specialist, graduate of the Medical University of Warsaw. Tomasz Tatara has several years of professional experience as an academic worker and as a pharmacoeconomics and HTA analyst. He acts as Head of the Health Policy Programme Division of the Technology Assessment Department at the Agency for Health Technology Assessment and Tariff System, . Former member of the Prevention Measures Coordination Team of the Minister of Health, the Team for the development of a recovery plan for cancer prevention strategies in relation to the SARS-COV-2 pandemic and the Team for systemic changes in public health. Currently, he is a member of the Provincial Council for health needs for the Warmian-Masurian Voivodeship. He is the author of numerous scientific publications, scripts, monograph chapters in the field of public health, healthcare, and pharmacoeconomics. Additionally, Tomasz Tatara has carried out numerous pharmacoeconomic analyses on the assessment of drug technologies available under drug programmes and health policy programmes. He gives lectures on public health and pharmacoeconomics at the Medical University of Warsaw. top

Victoria Thomas | UK | 2020
Victoria Thomas BA (Hons), MSc (Dist), Head of Public Involvement National Institute for Health and Care Excellence (NICE). Victoria Thomas has run the Public Involvement Programme at NICE since 2009, and has been with the Programme since 2001. Following a degree in Art History, Victoria has worked exclusively in the public and voluntary sector, specialising in healthcare quality improvement activities and in patient and public involvement. Victoria’s MSc, in Science and Society, concentrated on issues of science communication, science and the public, and lay people’s engagement with evidence-based healthcare initiatives. Victoria has an interest in shared decision-making, in particular the role of national clinical guidelines as the basis of informed decision-making by both patient and clinician. top

Krzysztof Tomasiewicz | Poland | 2023


Joanna Turkiewicz | Poland | 2024
Author of scientific publications, academic lecturer, and trainer with many years of experience. She is a practitioner in the field of using modern technology in education and academic writing. Joanna Turkiewicz has conducted trainings and workshops for physicians on image development on the Internet in cooperation with the Supreme Medical Chamber and on publishing scientific articles at the Maria Sklodowska-Curie National Research Institute of Oncology in Warsaw, where she is currently working. Her scientific interests revolve around patient experience and broadly understood healthcare. top


Mieczysław Walczak | Poland | 2016

Attorney-at-law and manager with many years of experience in public administration and advisory for the benefit of healthcare actors. She specialises in financing of healthcare services, including reimbursement of medicines and medical devices. Currently, she is a member of the management board of Technomed. Ewa co-authored the commentary on the Act on the Reimbursement of Medicines, Foodstuffs Intended for Particular Nutritional Uses and Medical Devices, as well as numerous practical commentaries on health care. She gained experience while working at the National Health Fund, the Agency for Health Technology Assessment and Tariff System (AOTMiT) and the Ministry of Health, where she held the position of Deputy Director at the Department of Drug Policy and Pharmacy and was responsible in particular for creating the drug policy in Poland, legislation, and reimbursement. Additionally, she was a member of the Tariff Council and represented Poland in various committees and working groups at the EU level. top

Björn Wettermark | Sweden | 2021

Wojtek Wiercioch | Canada | 2017

President of CEESTAHC Society, CEO of MedInvest Scanner, Vice President of HTA Consulting. In HTA Consulting, she is responsible for the strategic development of the company through research and services development, new product launch and marketing. Ms. Wladysiuk main and primary aim is to provide high quality information or data based on evidence based medicine or health technology assessment methodology not only in Poland but in Europe and Asia. Key role of her work is to improve patient outcomes through better healthcare decisions. In CEESTAHC she was responsible for the establishing and providing wide connection platform for discussion for all stakeholders in health care system. CEESTAHC mission is to improve the quality of health care systems value with the use of evidence. She graduatd Medical Academy in Lublin and MBA, economy in Kozminski Academy in Warsaw. She was Member of HTAi Annual Meeting in 2006-2008. top

Agnieszka Wojtecka | Poland | 2021

Marek Wójcik, healthcare expert at the Association of Polish Cities, Deputy Minister of Administration and Digitisation in the years 2014-2015, long-term participant of legislative works in the Polish Sejm and Senate; member of the health and social policy team of the Joint Commission of the Government and Local Governments and participant in the work of the Council for Social Dialogue. Since 2004, he has served three terms as chairman of the Council of the Małopolskie Regional Branch of the National Health Fund, an expert to the Minister of Health for restructuring healthcare facilities and ownership transformations (2009-2011), member of the Council for Public Health and of the Scientific Council of the National Influenza Control Programme. He supervises the activities of medical entities subordinate to the Sądecka Municipal Public Services Zone (pilot project), and the Nowy Sącz poviat. Author of publications on public health and health programmes created by local governments. In his didactic activity, he collaborates i.a. with the Cracow University of Economics, Lazarski University in Warsaw, Warsaw School of Economics, Medical University of Łódź, WSB – National Louis University in Nowy Sącz, and University of Business and Entrepreneurship in Ostrowiec Świętokrzyski. top

Wojciech Wysoczański | Poland | 2016

Michał Zabdyr-Jamróz | Poland | 2024
Political scientist, assistant professor at the Institute of Public Health of the Jagiellonian University Medical College. Collaborator of the European Observatory on Health Systems and Policies (Brussels) and the Partnership for Health System Sustainability and Resilience. Guest lecturer at the University of Copenhagen. Conducted research at, among others: Maastricht and Harvard universities. Presented his research at numerous conferences, including at: Sciences Po in Paris, as well as Universities of Manchester and Canberra. Areas of specialization and interest: health policy analysis; organization of health systems; deliberative democracy and deliberative governance; health equity and theories of justice; health in all policies (HiAP) and health impact assessment (HIA); challenges of evidence-based policy-making; and analysis of public debates on health and the above-mentioned issues. In his approach he utilises deliberative democratic theory, in particular the theory of deliberative systems, and the three inputs of governance framework – analysing intersection of emotions, self-interests and expertise in policy-making. He is also involved in the popularization of research as the founder of the Blog of the Institute of Public Health and the author of numerous popular science press publications. top

Vladimir Zah | Canada | 2016
Vladimir, PhD(c), brings more than 20 years of Health Economics technology and business experience. Since 2000, in various roles as Health Economist, Project Manager and Chief Investigator, Vlad has implemented more than 150 health economic models and assessments in the phase 2, 3 and 4 settings, across various disease areas for top 30 global pharmaceutical companies. Vlad worked extensively over the last 6 years in opioid dependence. His PhD research on early vs. late HIV detection in the United Kingdom contributed to revisions in HIV early detection policies made by the UK Parliament in 2011. He co-founded the Serbian Chapter of the International Society for Pharmaco-economics and Outcomes Research (ISPOR) in 2007 and served as President of that chapter until 2012. Vlad is an active member of various ISPOR special interest groups (SIG) (including rare diseases) and is ISPOR Central East Europe Executive Committee Chair 2015-2017. Vlad lectures extensively and serves as a key opinion leader in the areas of HEOR, opioid addiction, HIV, diabetes and other. He also consults and provided HEOR training relating to both medications and medical devices to Ministry of Health, National Insurance Funds or at national congresses in Russia, Turkey, Greece, Egypt, Poland, Czech Republic, Slovakia, Hungary, Croatia, Bosnia & Herzegovina, Slovenia, FYROM, Republic of Srpska and India. top

Zachary Zalewski | USA | 2022

Rafał Zasiewski | Poland | 2019

Wojciech Zawalski | Poland | 2016

Economist and social entrepreneur interested in complex systems, political economy of technology and digital economy. Co-President of the Polish Network of Economics and Program Director at CoopTech Hub, first Polish center for platform co-ops. PhD candidate at Kozminski University and lecturer at Management and AI in Digital Society program. Founder and 2015-2020 Chairman of the Board at Instrat, a progressive policy think-tank. He gained experience i.a. in the Polish Development Fund. Graduate of the Warsaw School of Economics, fellow of G20 Global Solutions, British Council, Møller Institute, Open Future Foundation & FEPS. Author of “Network Capitalism” (“Kapitalizm Sieci”), nominated to “Economicus 2020” prize. DigitalEU Ambassador. top